- Home
- Applications
- clinical stage
Refine by
Clinical Stage Product Applications
2 applications found
Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. ...
ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)
Standard Biopsy Limitations Traditionally, men suspected of prostate cancer undergo systematic biopsies guided by ultrasound imaging. Because ultrasound offers poor cancer visualization, 12 random samples are taken without knowing if there is cancer and if so, where it is. As a result, the cancer is either missed entirely, or if detected, is difficult to determine the extent and severity. This leads to under treatment of men with serious disease and overtreatment of men with indolent disease.4 ...
ByFocal Healthcare based in Toronto, ONTARIO (CANADA)